China Resources Boya Bio-pharmaceutical Group Co.,Ltd (SHE:300294)
China
· Delayed Price · Currency is CNY 17.72
+0.15 (0.85%)
Apr 29, 2026, 3:04 PM CST
SHE:300294 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 821.74 | 573.74 | 1,300 | 1,961 | 1,532 | 1,584 | Upgrade
|
| Short-Term Investments | 108.97 | 108.14 | - | - | - | - | Upgrade
|
| Trading Asset Securities | 1,946 | 2,549 | 2,199 | 3,362 | 3,194 | 2,700 | Upgrade
|
| Cash & Short-Term Investments | 2,876 | 3,231 | 3,499 | 5,324 | 4,726 | 4,284 | Upgrade
|
| Cash Growth | -14.09% | -7.67% | -34.28% | 12.66% | 10.31% | 468.21% | Upgrade
|
| Accounts Receivable | 886.83 | 919.69 | 509.38 | 275.92 | 567.02 | 588.08 | Upgrade
|
| Other Receivables | 56.56 | 49.17 | 39.81 | 264.4 | 100.62 | 67.9 | Upgrade
|
| Receivables | 943.39 | 968.86 | 549.19 | 540.32 | 667.64 | 655.98 | Upgrade
|
| Inventory | 1,029 | 996.2 | 995.43 | 556.94 | 666.96 | 676.84 | Upgrade
|
| Other Current Assets | 105.13 | 37.89 | 14.75 | 6.43 | 13.25 | 29.4 | Upgrade
|
| Total Current Assets | 4,954 | 5,234 | 5,058 | 6,428 | 6,073 | 5,646 | Upgrade
|
| Property, Plant & Equipment | 1,653 | 1,651 | 1,170 | 676.62 | 722.81 | 771.33 | Upgrade
|
| Long-Term Investments | 148.68 | 356.41 | 407.51 | 100.39 | 117.09 | 144.96 | Upgrade
|
| Goodwill | 617.53 | 617.53 | 728 | 72.61 | 663.84 | 663.84 | Upgrade
|
| Other Intangible Assets | 494.66 | 495.56 | 773.28 | 269.31 | 312.17 | 169.47 | Upgrade
|
| Long-Term Deferred Tax Assets | 81.56 | 83.23 | 73.54 | 47.34 | 44.99 | 27.44 | Upgrade
|
| Long-Term Deferred Charges | 144.58 | 145.29 | 145.9 | 88.15 | 82.64 | 161.62 | Upgrade
|
| Other Long-Term Assets | 311.39 | 43.84 | 44.38 | 146.83 | 16.24 | 37.2 | Upgrade
|
| Total Assets | 8,406 | 8,626 | 8,401 | 7,829 | 8,033 | 7,622 | Upgrade
|
| Accounts Payable | 290.54 | 507.51 | 357.62 | 126.35 | 303.46 | 277.53 | Upgrade
|
| Accrued Expenses | 75.47 | 421.14 | 323.81 | 274.14 | 290.9 | 261.19 | Upgrade
|
| Current Portion of Long-Term Debt | - | - | - | 0.03 | 22.18 | 0.08 | Upgrade
|
| Current Portion of Leases | 5.73 | 5.79 | 5.33 | 0.87 | 2.81 | 2.06 | Upgrade
|
| Current Income Taxes Payable | 15.48 | 2.08 | 12.44 | 8.58 | 27.09 | 41.45 | Upgrade
|
| Current Unearned Revenue | 15.46 | 8.12 | 4.08 | 12.21 | 20.58 | 12.97 | Upgrade
|
| Other Current Liabilities | 381.84 | 89.16 | 47.09 | 34.26 | 38.33 | 35.66 | Upgrade
|
| Total Current Liabilities | 784.51 | 1,034 | 750.38 | 456.45 | 705.34 | 630.94 | Upgrade
|
| Long-Term Debt | 58.31 | 47.07 | - | 22.15 | - | 22.15 | Upgrade
|
| Long-Term Leases | 11.22 | 12.73 | 7.17 | 1.4 | 10.37 | 11.3 | Upgrade
|
| Long-Term Unearned Revenue | 24.27 | 25.39 | 19.51 | 23.52 | 27.09 | 30.98 | Upgrade
|
| Long-Term Deferred Tax Liabilities | 64.5 | 68 | 136.32 | 4.56 | 5.56 | 5.94 | Upgrade
|
| Total Liabilities | 942.8 | 1,187 | 913.38 | 508.07 | 748.35 | 701.3 | Upgrade
|
| Common Stock | 504.25 | 504.25 | 504.25 | 504.25 | 504.25 | 511.63 | Upgrade
|
| Additional Paid-In Capital | 4,063 | 4,063 | 4,063 | 4,063 | 4,065 | 4,258 | Upgrade
|
| Retained Earnings | 2,904 | 2,874 | 2,918 | 2,753 | 2,616 | 2,259 | Upgrade
|
| Treasury Stock | - | - | - | - | - | -199.96 | Upgrade
|
| Comprehensive Income & Other | -9.47 | -3.52 | 2.36 | - | - | - | Upgrade
|
| Total Common Equity | 7,462 | 7,438 | 7,487 | 7,320 | 7,186 | 6,829 | Upgrade
|
| Minority Interest | 1.36 | 1.55 | 0.61 | 1.07 | 99.19 | 91.4 | Upgrade
|
| Shareholders' Equity | 7,463 | 7,439 | 7,488 | 7,321 | 7,285 | 6,920 | Upgrade
|
| Total Liabilities & Equity | 8,406 | 8,626 | 8,401 | 7,829 | 8,033 | 7,622 | Upgrade
|
| Total Debt | 75.26 | 65.59 | 12.51 | 24.45 | 35.36 | 35.58 | Upgrade
|
| Net Cash (Debt) | 2,801 | 3,165 | 3,486 | 5,299 | 4,690 | 4,248 | Upgrade
|
| Net Cash Growth | -16.05% | -9.22% | -34.21% | 12.99% | 10.41% | 903.09% | Upgrade
|
| Net Cash Per Share | 5.45 | 6.18 | 6.94 | 10.49 | 9.33 | 9.74 | Upgrade
|
| Filing Date Shares Outstanding | 504.25 | 504.25 | 504.25 | 504.25 | 504.25 | 504.25 | Upgrade
|
| Total Common Shares Outstanding | 504.25 | 504.25 | 504.25 | 504.25 | 504.25 | 504.25 | Upgrade
|
| Working Capital | 4,170 | 4,200 | 4,308 | 5,971 | 5,368 | 5,015 | Upgrade
|
| Book Value Per Share | 14.80 | 14.75 | 14.85 | 14.52 | 14.25 | 13.54 | Upgrade
|
| Tangible Book Value | 6,350 | 6,325 | 5,986 | 6,978 | 6,210 | 5,996 | Upgrade
|
| Tangible Book Value Per Share | 12.59 | 12.54 | 11.87 | 13.84 | 12.31 | 11.89 | Upgrade
|
| Buildings | - | 655.73 | 741.4 | 527.95 | 518.01 | 536.62 | Upgrade
|
| Machinery | - | 715.37 | 839.25 | 625.83 | 671.97 | 665.73 | Upgrade
|
| Construction In Progress | - | 938.57 | 321 | 39.94 | 69.34 | 40.86 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.